Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Buch
    Buch
    Hoboken, N.J. : Wiley
    UID:
    gbv_626732646
    Umfang: XIII, 494 S. , graph. Darst.
    ISBN: 9780470343425
    Anmerkung: Includes bibliographical references and index , Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan WangCentral glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemias associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current antidiabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. , Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism , Central glucose sensing and control of food intake and energy homeostasis , Abnormalities in insulin secretion in type 2 diabetes mellitus , Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae , Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis , Energy metabolism in skeletal muscle and its link to insulin resistance , Mechanisms and complications of metabolic syndrome , Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL , Mechanism of action of niacin : implications for atherosclerosis and drug discovery , Current anti-diabetic therapies and mechanisms , GLP-1 biology, signaling mechanisms, physiology, and clinical studies , Dipeptidyl peptidase IV inhibitors for treatment of diabetes , Sodium glucose co-transporter 2 inhibitors , Fibroblast growth factor 21 as a novel metabolic regulator , Sirtuins as potential drug targets for metabolic diseases , 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes , Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade , Drug development for metabolic diseases: past, present and future
    Sprache: Englisch
    Schlagwort(e): Metabolisches Syndrom
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz